Letters to the Editor
Early Access
Merkel cell carcinoma following photodynamic therapy in a high-risk patient
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 18 June 2026
705
Views
195
Downloads
Authors
Dear Editor,
Merkel cell carcinoma (MCC) is defined as a rare but highly aggressive skin cancer originating from neuroendocrine cells. Clinically, it usually appears as a rapidly growing, solid, asymptomatic, redviolaceous nodule. Its development is primarily associated with the integration of the Merkel cell polyomavirus (MCPyV) and extended exposure to ultraviolet (UV) radiation. The disease predominantly affects older individuals with fair skin. There is an increased incidence of MCC among immunocompromised individuals, such as patients suffering from hematological malignancies. [...]
Downloads
Download data is not yet available.
Citations
1. Toker C. Trabecular carcinoma of the skin: a question of title. Am J Dermatopathol 1982;4:497-500.
2. Becker JC, Stang A, DeCaprio JA, et al. Merkel cell carcinoma. Nat Rev Dis Primers 2017;3:17077.
3. Lugowska I, Becker JC, Ascierto PA, et al. Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open 2024;9:102977.
4. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375-81.
5. Borgia F, Giuffrida R, Caradonna E, et al. Early and late onset side effects of photodynamic therapy. Biomedicines 2018;6:12.
6. Ratour-Bigot C, Chemidling M, Montlahuc C, et al. Squamous cell carcinoma following photodynamic therapy for cutaneous Bowen’s disease in a series of 105 patients. Acta Derm Venereol 2016;96:658-63.
7. Mroz P, Szokalska A, Wu MX, et al. Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One 2010;5:e15194.
8. Giri U, Sharma SD, Abdulla M, et al. Evidence that in situ generated reactive oxygen species act as a potent stage I tumor promoter in mouse skin. Biochem Biophys Res Commun 1995;209:698-705.
9. Takahashi M, Fukuda H, Yokouchi Y, et al. Concurrent Merkel cell carcinoma and squamous cell carcinoma in a chest nodule. Eur J Dermatol 2015;25:492-4.
10. Narisawa Y, Inoue T, Nagase K. Dermal and intraepidermal Merkel cell carcinoma with squamous cell carcinoma: a report of a rare case with special reference to the touch dome. Am J Dermatopathol 2021;43:15-20.
How to Cite
1.
Polita F, Mengarino M, Carelli V, Hanspeter E, Saraceno R. Merkel cell carcinoma following photodynamic therapy in a high-risk patient. Dermatol Reports [Internet]. 2026 Jun. 18 [cited 2026 Jul. 10];. Available from: https://journals.pagepress.net/dr/article/view/10485
Copyright (c) 2026 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
